Pharmacokinetics of corticosteroids during pregnancy

Luis Pacheco, Labib M. Ghulmiyyah, Wayne R. Snodgrass, Gary Hankins

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Glucocorticoids constitute one of the most frequently prescribed medicines during pregnancy. Their use is the mainstay for a variety of maternal and fetal indications, both in acute and chronic settings. The pharmacokinetics of corticosteroids during pregnancy remains poorly understood. Significant pharmacologic alterations occur secondary to the profound changes in the renal, gastrointestinal, and cardiovascular systems during human gestation. Additional research on this topic is a significant priority to increase therapeutic benefit while minimizing side effects for both the mother and fetus when corticosteroids are prescribed during pregnancy. Certain obstetrical conditions such as preeclampsia and multiple gestations are associated with different volumes of distribution and clearance rates of medications, adding further complexity to the therapeutic use of glucocorticoids. This article reviews the available literature, including the most significant physiologic alterations of pregnancy and basic concepts of glucocorticoid pharmacology. Finally, theoretical assumptions about the potential pharmacokinetic changes of glucocorticoids in pregnancy and their application to clinical settings are discussed.

Original languageEnglish
Pages (from-to)79-82
Number of pages4
JournalAmerican Journal of Perinatology
Volume24
Issue number2
DOIs
StatePublished - Feb 2007

Fingerprint

Adrenal Cortex Hormones
Pharmacokinetics
Pregnancy
Glucocorticoids
Therapeutic Uses
Cardiovascular System
Pre-Eclampsia
Fetus
Mothers
Pharmacology
Kidney
Research

Keywords

  • Corticosteroids
  • Glucocorticoids
  • Pharmacokinetics
  • Pregnancy

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

Pharmacokinetics of corticosteroids during pregnancy. / Pacheco, Luis; Ghulmiyyah, Labib M.; Snodgrass, Wayne R.; Hankins, Gary.

In: American Journal of Perinatology, Vol. 24, No. 2, 02.2007, p. 79-82.

Research output: Contribution to journalArticle

Pacheco, Luis ; Ghulmiyyah, Labib M. ; Snodgrass, Wayne R. ; Hankins, Gary. / Pharmacokinetics of corticosteroids during pregnancy. In: American Journal of Perinatology. 2007 ; Vol. 24, No. 2. pp. 79-82.
@article{bba28a49a5ad4411bd6e2b6ce37d5506,
title = "Pharmacokinetics of corticosteroids during pregnancy",
abstract = "Glucocorticoids constitute one of the most frequently prescribed medicines during pregnancy. Their use is the mainstay for a variety of maternal and fetal indications, both in acute and chronic settings. The pharmacokinetics of corticosteroids during pregnancy remains poorly understood. Significant pharmacologic alterations occur secondary to the profound changes in the renal, gastrointestinal, and cardiovascular systems during human gestation. Additional research on this topic is a significant priority to increase therapeutic benefit while minimizing side effects for both the mother and fetus when corticosteroids are prescribed during pregnancy. Certain obstetrical conditions such as preeclampsia and multiple gestations are associated with different volumes of distribution and clearance rates of medications, adding further complexity to the therapeutic use of glucocorticoids. This article reviews the available literature, including the most significant physiologic alterations of pregnancy and basic concepts of glucocorticoid pharmacology. Finally, theoretical assumptions about the potential pharmacokinetic changes of glucocorticoids in pregnancy and their application to clinical settings are discussed.",
keywords = "Corticosteroids, Glucocorticoids, Pharmacokinetics, Pregnancy",
author = "Luis Pacheco and Ghulmiyyah, {Labib M.} and Snodgrass, {Wayne R.} and Gary Hankins",
year = "2007",
month = "2",
doi = "10.1055/s-2006-958162",
language = "English",
volume = "24",
pages = "79--82",
journal = "American Journal of Perinatology",
issn = "0735-1631",
publisher = "Thieme Medical Publishers",
number = "2",

}

TY - JOUR

T1 - Pharmacokinetics of corticosteroids during pregnancy

AU - Pacheco, Luis

AU - Ghulmiyyah, Labib M.

AU - Snodgrass, Wayne R.

AU - Hankins, Gary

PY - 2007/2

Y1 - 2007/2

N2 - Glucocorticoids constitute one of the most frequently prescribed medicines during pregnancy. Their use is the mainstay for a variety of maternal and fetal indications, both in acute and chronic settings. The pharmacokinetics of corticosteroids during pregnancy remains poorly understood. Significant pharmacologic alterations occur secondary to the profound changes in the renal, gastrointestinal, and cardiovascular systems during human gestation. Additional research on this topic is a significant priority to increase therapeutic benefit while minimizing side effects for both the mother and fetus when corticosteroids are prescribed during pregnancy. Certain obstetrical conditions such as preeclampsia and multiple gestations are associated with different volumes of distribution and clearance rates of medications, adding further complexity to the therapeutic use of glucocorticoids. This article reviews the available literature, including the most significant physiologic alterations of pregnancy and basic concepts of glucocorticoid pharmacology. Finally, theoretical assumptions about the potential pharmacokinetic changes of glucocorticoids in pregnancy and their application to clinical settings are discussed.

AB - Glucocorticoids constitute one of the most frequently prescribed medicines during pregnancy. Their use is the mainstay for a variety of maternal and fetal indications, both in acute and chronic settings. The pharmacokinetics of corticosteroids during pregnancy remains poorly understood. Significant pharmacologic alterations occur secondary to the profound changes in the renal, gastrointestinal, and cardiovascular systems during human gestation. Additional research on this topic is a significant priority to increase therapeutic benefit while minimizing side effects for both the mother and fetus when corticosteroids are prescribed during pregnancy. Certain obstetrical conditions such as preeclampsia and multiple gestations are associated with different volumes of distribution and clearance rates of medications, adding further complexity to the therapeutic use of glucocorticoids. This article reviews the available literature, including the most significant physiologic alterations of pregnancy and basic concepts of glucocorticoid pharmacology. Finally, theoretical assumptions about the potential pharmacokinetic changes of glucocorticoids in pregnancy and their application to clinical settings are discussed.

KW - Corticosteroids

KW - Glucocorticoids

KW - Pharmacokinetics

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=33847669348&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847669348&partnerID=8YFLogxK

U2 - 10.1055/s-2006-958162

DO - 10.1055/s-2006-958162

M3 - Article

VL - 24

SP - 79

EP - 82

JO - American Journal of Perinatology

JF - American Journal of Perinatology

SN - 0735-1631

IS - 2

ER -